This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
November 9–11, 2026
KoelnmesseCologne, Germany
Register
Menu
Register

Stephane Thiroloix
CEO at Apikal Therapeutics
Speaker

Profile

Funding for ST420's development to Clinical POC

Professional background

Stephane joined Apikal Therapeutics in July 2025 as CEO. He previously founded and led AlgoTx, a European supportive care biotech.

Experienced Pharma and Biotech Leader, multicultural Board Member.

Thirty years in the Pharma, Biotech & MedTech Industry on 4 continents in functions across commercial, industrial, development, strategy, affiliate management, ExCom and CEO.

Founder and CEO of a biotech from research to late clinical stage : creation, strategy, execution, raised 35 M€, VC funds.

Governance on the operational side (public, private and family-owned companies), and Board Chair / Member in France and abroad.

Agenda Sessions

  • Women’s Health at an Inflection Point: Redefining Treatment, Regulatory Pathways and Access

    , 12:20
    View Session

At this event

Prev
Next
Jeremy Levin
Executive Chairman
Ovid Therapeutics Inc

See Stephane at BIO-Europe

Register